TAU SINGLE DOMAIN ANTIBODIES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 29, 2023
app pub date -
Feb 19, 2019
filing date -
May 17, 2018
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The present disclosure is directed to single domain antibodies that bind to tau and the use of these antibodies for the treatment and diagnosis of tauopathies. The present disclosure is also directed to polynucleotides encoding the tau single domain antibodies, therapeutic vectors comprising these polynucleotides and methods of administering these therapeutic vectors for the treatment of tauopathies.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully